BUZZ-Truist updates ratings on health insurers for 2026

Reuters01-05
BUZZ-Truist updates ratings on health insurers for 2026

** Truist Securities updates price targets and ratings on health insurers

** Reiterates "buy" for Cigna CI.N; says Evernorth’s operating income is expected to dip slightly in 2026 due to lower PBM revenue, while specialty and care services should grow at the high end of Cigna’s long-term rang

** Maintains "buy" for Centene CNC.N; expects profit margins to improve in marketplace and Medicare advantage businesses, while Medicaid margins stay "roughly consistent with 2025"

** Reiterates "buy" for CVS Health CVS.N; cites diversified assets, ongoing margin improvement opportunities and expects margins in-line with historical levels at about 4%

** Maintains "buy" on Elevance Health ELV.N and UnitedHealth Group UNH.N; cites scale, diversified offerings and ongoing investment in automation and AI

** Expects both ELV and UNH to see margin recovery in Medicaid and Medicare, with ongoing capital deployment supporting growth

Company

Old PT

New PT

Cigna group

$310

$320

Centene

$45

$47

CVS Health

$95

$98

Elevance Health

$385

$400

United Health

$400

$410

(Reporting by Siddhi Mahatole)

((siddhi.mahatole@thomsonreuters.com))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment